Trade Ideas September 29, 2026 05:43 AM

Buying Oracle After the AI Capex Shock - A Tactical Long at $132.72

Cloud infrastructure spending has battered the stock, but revenue momentum, a huge backlog and attractive valuation vs. long-term upside make this a tactical buy.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
ORCL

Oracle is trading roughly 59% below its 52-week high despite strong cloud revenue growth, a $600B+ backlog and improving profitability. The market is punishing heavy capex and negative free cash flow today; that creates a tactical long opportunity around $132.72 with defined stops and staged targets across 10- to 180-trading-day horizons.

Buying Oracle After the AI Capex Shock - A Tactical Long at $132.72
ORCL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Oracle trades at $132.72 with a market cap near $401B, roughly 59% below its 52-week high of $322.54.
  • Earnings remain positive (EPS ~$6.18, P/E ~21.45), but free cash flow is negative at -$28.72B due to heavy AI-era capex.
  • Trade plan: Buy at $132.72, stop $115.00, primary target $175.00 (mid term - 45 trading days); consider longer-term upside to $240 if FCF normalizes.
  • Catalysts include progress on Project Jupiter, backlog conversion, and visible improvements in FCF and cloud margins.

Hook and thesis

Oracle is down roughly 59% from its 52-week high of $322.54 and is trading at $132.72 after a selloff driven by aggressive AI infrastructure spending and a near-term hit to free cash flow. I view that pullback as an opportunity to buy a high-quality enterprise-software-and-cloud incumbent where the market has overstated the permanence of margin degradation and underpriced the optionality from enterprise AI demand. This is a tactical long: defined entry, a clear stop under recent lows, and staged upside targets keyed to catalysts around Project Jupiter, backlog conversion and a path back to positive free cash flow.

Put simply: the short-term pain looks priced in, valuation multiples are reasonable for a company with $401B market cap and strong ROE, and the probability of upside over the next 45-180 trading days is attractive relative to risk. I will outline why, the numbers that matter, and a concrete trade plan below.

What Oracle actually does - and why the market should care

Oracle sells enterprise applications, infrastructure technologies and cloud services. It operates three segments: Cloud and License, Hardware, and Services. The company is pivoting hard into high-performance cloud infrastructure for AI workloads, which requires heavy upfront capital but targets a much larger addressable market as enterprises and AI developers demand dedicated compute and data pipelines.

Why this matters: enterprise IT budgets are shifting toward AI and large-scale cloud deployments. Oracle is trying to capture both software spend (subscription and licenses) and the high-margin recurring services tied to cloud infrastructure. A successful transition would re-rate the stock; failure or stretched balance-sheet dynamics would keep it depressed. The current price reflects the market picking the latter as the higher probability — that creates a tactical asymmetric opportunity for buyers who size risk and set hard stops.

Key fundamentals and what the numbers say

  • Current price: $132.72 (market cap roughly $401B).
  • Earnings: EPS ~$6.18, P/E ~21.45.
  • Enterprise value: ~$490.9B, EV/EBITDA ~13.85x, EV/Sales ~6.84x.
  • Free cash flow is negative: -$28.72B (reflecting heavy capex for data centers and AI infrastructure).
  • Balance sheet and returns: debt-to-equity ~1.88x, return on equity ~28.06%, current ratio ~1.17x.
  • Dividend: quarterly payment of $0.50 (ex-dividend 10/09/2026), yield ~1.46%.
  • Technicals: RSI ~37 (oversold), 10-day SMA ~143.33, 50-day SMA ~142.37. Short interest low in days-to-cover terms (~1.36 days on the latest reading).

Two items stand out. First, Oracle still generates earnings (EPS ~$6.18) and posts strong profitability metrics like ROE of 28%. That argues the core business remains profitable even while the company spends heavily to build AI infrastructure. Second, cash flow is currently negative by a large margin (-$28.72B free cash flow), which is the immediate reason investors are nervous. The market is essentially valuing Oracle more like a capital-intensive infrastructure builder than a steady software cash machine today.

Valuation framing

At ~21.5x trailing earnings and EV/EBITDA ~13.85x, Oracle is not trading like a busted growth story or an unprofitable cloud pure-play. The valuation is in line with mature technology companies that have some cyclical risk. The negative free cash flow and heavy capex push the story toward a lumpy short-term outlook, but if management demonstrates a path to stabilizing FCF and begins to monetize AI infrastructure at scale, the company could re-rate toward higher EV/EBITDA multiples that reflect recurring cloud economics.

Compare history qualitatively: the stock is now materially lower than its 52-week high of $322.54 (10/16/2025), reflecting a market reaction to execution risk and capex pace rather than a fundamental collapse of demand for Oracle's products. If Oracle converts backlog and starts to show improving FCF with steady revenue growth, the current multiples would look conservative.

Catalysts to drive the trade

  • Progress on Project Jupiter and public milestones that demonstrate expected performance and costs for AI workloads. Positive progress would reduce uncertainty around capex payback.
  • Backlog conversion: reports cite a sizeable backlog (one article references >$600B). If management begins to convert that backlog into recognized revenue and visible service revenue, the top line will accelerate and offset some capex concerns.
  • Improving free cash flow as capex growth slows or as higher-margin cloud services scale, reducing the negative FCF drag that is pressuring the multiple today.
  • Any incremental partnership or marquee customer wins for Oracle's AI compute platform - tangible usage or pricing announcements that show demand for dedicated AI infrastructure.

Trade plan (actionable)

Entry: $132.72 (current price). Stop loss: $115.00 - set below the 52-week low of $114.50 to give the trade room while protecting against a deeper break. Primary target: $175.00 for the mid-term objective.

Metric Value
Entry $132.72
Stop loss $115.00
Primary target (mid-term) $175.00
Horizon (primary) mid term (45 trading days)
Alternate horizon long term (180 trading days) - second-stage target $240 (see notes below)

How to manage the trade across horizons:

  • Short term (10 trading days): expect volatility and news-driven whipsaws. Consider a small initial position (25%-33% of target allocation) to buy volatility if the stock dips toward $125-128.
  • Mid term (45 trading days): target $175. This is the primary time frame for the trade — enough time for catalysts like a constructive update on Project Jupiter or a quarterly read on backlog conversion to affect sentiment.
  • Long term (180 trading days): if catalysts play out, scale out toward $240 as cloud revenue and FCF begin normalizing. If free cash flow remains deeply negative or the company signals more capex ahead without a clear ROI path, tighten stops or exit.

Risks and counterarguments

  • Execution risk on AI infrastructure: Oracle's heavy capex (reports show a $28.5B quarter and a multi-year Project Jupiter spend) could continue to overwhelm cash flow. If unit economics for Oracle's AI cloud don't improve, the company may need to slow investment or raise capital, both negative for the stock.
  • Negative free cash flow persists: Free cash flow is currently -$28.72B. Continued negative FCF will limit buybacks/dividends and could pressure credit metrics if capex doesn't convert to recurring revenue quickly.
  • Competitive intensity: Oracle competes with hyperscalers and specialized accelerator vendors. Competitors with larger existing AI ecosystems could win disproportionate share, compressing Oracle's margin potential.
  • Execution delays and cost overruns: Project Jupiter or other major builds can be delayed or expensive; the market punished similar narratives at other cloud players. Delays would likely push the stock lower before recovery is possible.
  • Macro risk and market multiple compression: If risk-off conditions return, even fundamentally sound tech companies can reprice lower, which would hurt this position.

Counterargument to my thesis: The bear case is simple and plausible — Oracle is spending aggressively to build a capital-intensive AI data center footprint without a clear path to economic payback. If demand for on-prem or Oracle-specific AI compute fails to materialize at scale, the company could be stuck with stranded capacity and a permanently lower multiple. That outcome would make patience expensive and could invalidate the trade.

Why I still prefer the long here

There are three balancing facts: first, core profitability remains (EPS ~$6.18; ROE ~28%), so the business isn't broken. Second, significant backlog figures have been cited in coverage (> $600B in some reports), which implies demand that can be monetized over time. Third, the valuation doesn't assume a runaway winner in AI infrastructure; at roughly 21x earnings and EV/EBITDA ~13.85x, the stock can rerate meaningfully on improved FCF without requiring speculative multiple expansion.

What would change my mind

  • Evidence that backlog is evaporating rather than converting to revenue - public retracts or large customer cancellations would make me exit.
  • Guidance that extends negative FCF materially beyond current market expectations or additional large capital raises that dilute shareholders’ long-term economics.
  • Conversely, if management provides concrete metrics showing improving gross margins on cloud services, accelerating recurring revenue, and a roadmap to positive FCF within 2-3 quarters, I would increase conviction and scale the position.

Conclusion - clear stance

Oracle at $132.72 is a tactical long with a mid-term target of $175 and a stop at $115. The market has punished the stock for valid reasons — heavy capex and negative FCF — but the company still generates earnings, has high ROE, and sits on mobile tailwinds as enterprises invest in AI. Buy size should reflect the binary nature of the outcome: a staged entry with disciplined stops and position-sizing is the prudent way to capture upside while respecting the real execution risks.

Trade summary: Buy ORCL at $132.72. Stop loss $115.00. Primary target $175.00 (mid term - 45 trading days). Scale to higher targets only if FCF and backlog conversion metrics improve over the next two quarters.

Risks

  • Execution risk on AI infrastructure - cost overruns or weak demand could make capex unproductive.
  • Sustained negative free cash flow (-$28.72B) could constrain capital allocation and press the stock lower.
  • Competitive pressure from hyperscalers and specialized accelerator vendors could compress pricing and margins.
  • Project delays or setbacks for key data center investments would prolong uncertainty and cap valuation upside.

More from Trade Ideas

Rubrik: Position for a Free Cash Flow Re-rating as Enterprise Demand Accelerates Sep 29, 2026 Buy KLA While the AI-Packaging Momentum Is Still Cheap Relative to the Upside Sep 29, 2026 EPD Upgrade: Distribution Momentum Is Back — Time to Buy the Yield and Growth Re-Rate Sep 29, 2026 Intel: A Profitable Trade on Strong Fundamentals — With a Clock Ticking on Sentiment Sep 29, 2026 Nike's Turnaround Is a Time Arbitrage - Buy for the 180-Day Rebound Sep 29, 2026